Labgenius Therapeutics ("Labgenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVA™, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation, and synthetic biology. While EVA™ is both modality and format-agnostic, Labgenius' internal pipeline is focused on the development of selectivity-enhanced antibodies for the treatment of solid tumors. The company's novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.

England, UK

London, UK

South West England, UK

Mile End, London, UK

Kingston Vale, London SW15, UK

LabGenius

At Kindred we align our ambitions and achievements with our portfolio - in structure and in spirit. Every entrepreneur we invest in becomes a co- owner of the fund. We call it ‘equitable venture’. We invest early and work with our community of founders and advisers to help founders get further, faster from the very beginning.

Kindred Capital

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Kindred Capital Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Kindred Capital network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Kindred Capital company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Search jobs within our portfolio